29 April 2004 & 8 July 2004: The Federal Public Service Health, Food chain safety and Environment gives a final decision (positive) for this trial.
Trial reference:
Phase I multicentre study of TG1024 (Adenovirus interleukin 2) in patients with metastatic melanoma or other advanced solid tumor cancers